Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us

  • Get The Newsletter!
  • View The Latest Newsletter
  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory
  • Resource Centers
    • Medtech Regulatory Resource Center
    • EU MDR and IVDR Resource Center
    • Medical Device Labeling Resource Center
    • Medical Device Audits, Certification & Verification
    • Medical Device Component
    • Medical Recall Resource Center
  • Events & Webinars
  • Library

Product Design & Development

Whitehouse 2021
October 5, 2022
Whitehouse 2021

White Houses Releases AI Bill of Rights Blueprint

By MedTech Intelligence Staff
No Comments

On Tuesday, October 4, the White House released a Blueprint for an Artificial Intelligence (AI) Bill of Rights geared toward protecting the American public as the use of AI and machine learning expands throughout industry and online.

Continue reading →

Laura Jones
September 27, 2022
Laura Jones
Soapbox

A Single Source of Truth Helps Regulatory Teams

By Laura Jones
No Comments

The deeper insights provided by a single source of truth help regulatory teams pinpoint and address gaps in data collection during each trial phase. By mitigating potential risks earlier in the process, teams generate more robust evidence and stronger submissions, which often means a shorter approval process.

Continue reading →

Mohamed Benkirane
September 21, 2022
Mohamed Benkirane
MEDdesign

Raising the Bar on Quality for MedTech Production

By Mohamed Benkirane
No Comments

Inspecting for quality after a process is completed is reactive and outdated. Instead, the future lies in predicting quality and quality issues. For medical device manufacturers, the advantages in predictive quality are so great they simply cannot be ignored.

Continue reading →

Veranex logo
September 20, 2022
Veranex logo

Veranex Acquires Medidee

By MedTech Intelligence Staff
No Comments

The acquisition expands Veranex’s European footprint as well as the scale and scope of its clinical studies capabilities.

Continue reading →

Mike Noshay
September 14, 2022
Mike Noshay

The Perils of Biased Data

By Mike Noshay
No Comments

The reality of biased data is becoming all too clear, which raises important questions for clinicians as well as device and drug developers. In a world full of biased data what are the most ethical practices to achieve equitable health care?

Continue reading →

Whitehouse 2021
September 12, 2022
Whitehouse 2021

Pres. Biden Issues Executive Order on Advancing Biotechnology and Biomanufacturing

By MedTech Intelligence Staff
No Comments

The order outlines a “whole-of-government approach” to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience and national and economic security.

Continue reading →

Blood pressure
July 27, 2022
Blood pressure

Tonometry Superior for Cuffless Blood Pressure Monitoring

No Comments

Tonometry-derived features showed superior performance compared to other feature groups and baselines, while younger and normotensive subjects had the most consistent readings across all feature groups.

Continue reading →

MilliporeSigma
July 25, 2022
MilliporeSigma

Construction Begins on U.S.-based Lateral Flow Membrane Production Facility

By MedTech Intelligence Staff
No Comments

MilliporeSigma received a $136.7 million contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services (HHS), to support the new facility. It will be the company’s first U.S.-based facility capable of producing diagnostic-grade membrane.

Continue reading →

Brian Stallard, AAMI
July 25, 2022
Brian Stallard, AAMI

Man vs. Machine—Or More of a Partnership?

By Brian Stallard
No Comments

Is technology replacing the human element in hospitals and clinics, or enhancing it? In this AAMI Research Review, a pair of newly published studies exemplify how accounting for the humans that use a technology can enhance its effectiveness… and vice versa.

Continue reading →

Harvard SEAS/Michael Rosnach
July 12, 2022
Harvard SEAS/Michael Rosnach

Harvard Bioengineers Develop Biohybrid Heart Ventricles

By MedTech Intelligence Staff
No Comments

The research team used focused rotary jet spinning to create polymeric materials that were then seeded with cardiomyocytes to create a biohybrid model of human ventricles with helically aligned beating cardiac cells.

Continue reading →

Post navigation

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 93
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.

FST's COVID-19 Resource Center



Topic Archives

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Column Archives

  • Ameing for Asia
  • Ask the Engineer
  • CAPA Corner
  • Devine Guidance
  • From The Editor’s Desk
  • MEDdesign
  • Reimbursement Report
  • Soapbox

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2023 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.